RHUMBLINE ADVISERS

Position in OVID — Ovid Therapeutics Inc.

CIK 1115418 BOSTON, MA

Position in OVID

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$457,673

+$432,427 QoQ

Shares Held

170,139

+110.3% QoQ

Ownership

0.087%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#46

of 131 holders

Holding Since

Jun 2020

13 quarters on record

Voting authority Sole 21% Shared 0% None 79%

Healthcare · as of Jun 30, 2026

RHUMBLINE ADVISERS holds $1,404,724,682 across 329 Biotechnology names. OVID ranks #189 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	396,380	$196,893,837
2	REGN	Regeneron Pharmaceuticals, Inc.	157,794	$98,390,870
3	MRNA	Moderna, Inc.	809,853	$56,714,005
4	ALNY	Alnylam Pharmaceuticals, Inc.	165,579	$49,844,246
5	INCY	Incyte Corp	428,533	$48,578,500
6	RVMD	Revolution Medicines, Inc.	226,008	$42,326,778
7	ROIV	Roivant Sciences Ltd.	1,178,789	$41,717,342
8	JAZZ	Jazz Pharmaceuticals plc	163,018	$39,282,447

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$457,673	170,139	+110.3%	Shares	Sole	2026-08-12
2025-03-31	$25,246	80,917	-3.8%	Shares	Sole	2025-05-29
2024-12-31	$78,528	84,078	+22.3%	Shares	Sole	2025-05-29
2024-09-30	$81,093	68,723	-1.4%	Shares	Sole	2024-11-12
2024-06-30	$53,624	69,733	-15.6%	Shares	Sole	2024-08-01
2024-03-31	$251,881	82,584	+3.7%	Shares	Sole	2024-05-09
2023-12-31	$256,524	79,666	-3.8%	Shares	Sole	2024-02-08
2023-09-30	$317,917	82,791	+5.1%	Shares	Sole	2023-11-09
2023-06-30	$258,359	78,768	+60.8%	Shares	Sole	2023-08-08
2021-03-31	$196,939	48,990	-1.4%	Shares	Sole	2021-05-06
2020-12-31	$114,737	49,670	+7.3%	Shares	Sole	2021-02-10
2020-09-30	$265,647	46,280	-4.0%	Shares	Sole	2020-11-12
2020-06-30	$355,418	48,225	—	Shares	Sole	2020-08-13
No filing history on record for this holder in this stock.